Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases
癌症-神经-免疫轴的反卷积和中断促进脑转移
基本信息
- 批准号:10747824
- 负责人:
- 金额:$ 7.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-01 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:ArchitectureBrainBreastBreast Cancer PatientClinical ResearchEnvironmentEthnic OriginExhibitsFormalinGenesImmuneImmune ToleranceIn SituIncidenceInfiltrationInterruptionMacrophageMalignant NeoplasmsMapsMetastatic malignant neoplasm to brainMolecularMultiplexed Ion Beam ImagingNeoplasm MetastasisNeuroimmuneParaffin EmbeddingPathologyPatient-Focused OutcomesPatientsPrimary NeoplasmProteinsRaceResolutionSocioeconomic FactorsTechnologyTissue MicroarrayTissue SampleUp-RegulationVariantWomanblack patientblack womenbreast cancer progressiondensitydifferential expressionhigh dimensionalityimmunoregulationmalignant breast neoplasmmortalityneoplastic cellneuropathologypreclinical studyprognosticationracial populationtargeted treatmenttumortumor microenvironmenttumor-immune system interactions
项目摘要
Black women exhibit a significantly higher incidence and mortality from breast-to-brain
metastasis. This difference in cancer incidence and patient outcomes cannot be solely
explained by cultural and socioeconomic factors necessitating the need to identify
molecular mechanisms governing these differences. Preclinical and clinical studies have
discovered differences in tumor microenvironment (TME) composition and architecture
that are distinct in breast cancers from Black patients. Microvessel density, macrophage
infiltration, and upregulation of immune-related genes have been shown to exist in Black
women compared to White women supporting the idea that ethnic variation can contribute
to distinct changes in the TME. Little is known about the immune environment in breast
cancer brain metastases especially in Black patients. We hypothesize that increased
incidence and progression of breast cancer in Black women is in part due to race-based
differences in tumor-immune interactions. This proposal will examine how the spatial
architecture of the TME reflects distinct tumor-immune interactions, and how these
interactions prime systemic immune tolerance of disseminated tumor cells, enabling
brain-specific metastases.
Stanford Pathology and Neuropathology departments have constructed a tissue
microarray (TMA) containing brain metastases and primary tumors from a diverse group
of breast cancer patients. We will characterize the spatial architecture of these TMAs
using multiplexed ion beam imaging (MIBI). MIBI is a cutting -edge technology that
enables simultaneous quantification of up to 39 proteins in formalin-fixed, paraffin-
embedded tissue samples to create high dimensional tumor-immune maps at subcellular
resolution. Using MIBI, we will construct in-situ subcellular protein spatial maps of both
primary breast cancer and breast cancer brain metastases TME. We will subsequently
identify features of the primary and brain metastases TMEs that are differentially
expressed between Black women and other racial groups. We will focus on identifying
features of the tumor-immune microenvironment (immune composition, spatial
architecture, tumor-immune interactions) that vary based on patient race. The results from
this project will be instrumental in developing appropriate prognostication and targeted
therapies for Black women with breast cancer.
黑人妇女从乳房到脑部的发病率和死亡率明显更高
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melanie Hayden Gephart其他文献
Melanie Hayden Gephart的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melanie Hayden Gephart', 18)}}的其他基金
Investigate and inhibit microglia support of brain metastases
研究并抑制小胶质细胞对脑转移的支持
- 批准号:
10272360 - 财政年份:2021
- 资助金额:
$ 7.64万 - 项目类别:
Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases
癌症-神经-免疫轴的反卷积和中断促进脑转移
- 批准号:
10927523 - 财政年份:2021
- 资助金额:
$ 7.64万 - 项目类别:
Investigate and inhibit microglia support of brain metastases
研究并抑制小胶质细胞对脑转移的支持
- 批准号:
10929588 - 财政年份:2021
- 资助金额:
$ 7.64万 - 项目类别:
Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases
癌症-神经-免疫轴的解卷积和中断促进脑转移
- 批准号:
10706491 - 财政年份:2021
- 资助金额:
$ 7.64万 - 项目类别:
Investigate and inhibit microglia support of brain metastases
研究并抑制小胶质细胞对脑转移的支持
- 批准号:
10706495 - 财政年份:2021
- 资助金额:
$ 7.64万 - 项目类别:
Identifying and Targeting Shared Molecular Characteristics of Breast- and Melanoma-Derived Brain Metastases
识别和靶向乳腺和黑色素瘤脑转移瘤的共同分子特征
- 批准号:
10831246 - 财政年份:2021
- 资助金额:
$ 7.64万 - 项目类别:
Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases
癌症-神经-免疫轴的反卷积和中断促进脑转移
- 批准号:
10272357 - 财政年份:2021
- 资助金额:
$ 7.64万 - 项目类别:
(PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche
(PQ1) 识别和靶向在瘤周微环境中迁移的人类胶质母细胞瘤
- 批准号:
9883759 - 财政年份:2017
- 资助金额:
$ 7.64万 - 项目类别:
相似国自然基金
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
- 批准号:81801389
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
平扫描数据导引的超低剂量Brain-PCT成像新方法研究
- 批准号:81101046
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Roles of Glial Autophagy in Breast Cancer Brain Metastasis
胶质细胞自噬在乳腺癌脑转移中的作用
- 批准号:
10660141 - 财政年份:2023
- 资助金额:
$ 7.64万 - 项目类别:
Targeting FASN to eliminate metastatic breast cancer in the brain
靶向 FASN 消除脑部转移性乳腺癌
- 批准号:
10721671 - 财政年份:2023
- 资助金额:
$ 7.64万 - 项目类别:
Targeting brain and bone metastases in metastatic breast cancer for improved patient survival
针对转移性乳腺癌的脑和骨转移,提高患者生存率
- 批准号:
10564604 - 财政年份:2023
- 资助金额:
$ 7.64万 - 项目类别:
Breast Cancer Brain Metastasis Therapy by Focused Ultrasound-Guided Control of HER2 CAR T cells
通过聚焦超声引导控制 HER2 CAR T 细胞治疗乳腺癌脑转移
- 批准号:
10668038 - 财政年份:2023
- 资助金额:
$ 7.64万 - 项目类别:
Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis
乳腺癌脑转移的增强病毒免疫疗法
- 批准号:
10803696 - 财政年份:2023
- 资助金额:
$ 7.64万 - 项目类别:
Targeting DNA repair mechanisms by nanoparticles of RNA and radiosensitizer for enhancing treatment of brain metastases of breast cancer
通过 RNA 纳米颗粒和放射增敏剂靶向 DNA 修复机制,增强乳腺癌脑转移的治疗
- 批准号:
488264 - 财政年份:2023
- 资助金额:
$ 7.64万 - 项目类别:
Operating Grants
Novel drug delivery strategies for treatment of breast cancer brain metastases
治疗乳腺癌脑转移的新型药物递送策略
- 批准号:
10367645 - 财政年份:2022
- 资助金额:
$ 7.64万 - 项目类别:
Role of breast cancer secreted miRNA in brain metastasis
乳腺癌分泌的miRNA在脑转移中的作用
- 批准号:
10342786 - 财政年份:2022
- 资助金额:
$ 7.64万 - 项目类别:
Light Physical Activity for Brain Health in Older Adult Breast Cancer Survivors
轻度体力活动有利于老年乳腺癌幸存者的大脑健康
- 批准号:
10464004 - 财政年份:2022
- 资助金额:
$ 7.64万 - 项目类别:
Assessment of cerebrospinal fluid ctDNA for the development of systemic therapy for brain metastases and leptomeningea disease of HER2-negative breast cancer
脑脊液 ctDNA 评估用于 HER2 阴性乳腺癌脑转移和软脑膜疾病全身治疗开发
- 批准号:
22K15565 - 财政年份:2022
- 资助金额:
$ 7.64万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




